Publicación: Informal sale of antibiotics in Guatemalan convenience stores before and after implementation of federal antibiotic dispensing legislation
Portada
Abstract_Informal sale of antibiotics in Guatemalan convenience stores before and after implementation of federal antibiotic dispensing legislation (2).pdf
Citas bibliográficas
Código QR
Autor corporativo
Recolector de datos
Otros/Desconocido
Director audiovisual
Editor
Tipo de Material
Fecha
Citación
Título de serie/ reporte/ volumen/ colección
Es Parte de
Resumen
Background Convenience stores in Guatemala provide essential consumer goods in communities, but many dis‑ pense antibiotics illegally. Federal legislation, passed in August of 2019, requires prescriptions for antibiotic purchase at pharmacies but it is unclear if this legislation is enforced or if it has any impact on unlawful sales of antibiotics. Methods To determine if antibiotic availability changed in convenience stores, we carried out a repeated measures study collecting antibiotic availability data before and after implementation of the dispensing regulation. Results There was no statistical diference in the proportion of convenience stores that sold antibiotics before and after antibiotic regulations [66.6% (295/443) and 66.7% (323/484), respectively, P>0.96], nor in the number of stores selling amoxicillin [55.5% (246/443) and 52.3% (253/484), respectively, P>0.96], but fewer stores (20%) sold tetracycline capsules after regulation was passed (P<0.05). For stores visited both before and after passage of legisla‑ tion (n=157), 15% stopped selling antibiotics while 25% started selling antibiotics. Antibiotics from convenience stores were reportedly sold for use in people and animals. Conclusions Antibiotics remain widely available in convenience stores consistent with no signifcant change in the informal sector after implementation of prescription requirements for pharmacies. Importantly, efects from regulatory change could have been masked by potential changes in antibiotic use during the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic.